By Edward Winnick

SAN FRANCISCO (GenomeWeb News) – With initial efforts aimed at bringing its circulating tumor cell platform to drug development researchers, On-Q-ity also has its sights set on the clinic, pharmacogenomics market, and detection of additional kinds of cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.